Order — ECLI:EU:C:2017:148
Date: 2017-03-01
Language of the case: English
Court formation: Vice-President
Subject matter: Provisions governing the Institutions;Access to documents
Procedure: Action for annulment;Appeal - inadmissible;Application for interim measures
Origin: Netherlands

summary (Arts 278 TFEU and 339 TFEU; Charter of Fundamental Rights of the European Union, Art. 7; European Parliament and Council Regulation No 1049/2001, Art. 4(2), first indent) (see paras 134, 135, 139, 141) Operative part 1. The appeal is dismissed. 2. The European Medicines Agency (EMA) is, in addition to bearing its own costs, to pay the costs incurred by PTC Therapeutics International Ltd relating to the appeal proceedings. 3. The European Confederation of Pharmaceutical Entrepreneurs (Eucope) is to bear its own costs relating to the appeal proceedings.